|
Biotechnology
|
09-05-07
UTSA EMERGING INFECTIOUS DISEASE RESEARCHERS LEAD PUSH TO BRING
Facility would foster collaborations and provide internship and employment opportunities
Read this story...
|
| other stories: |
05-18-07
San Antonio Life Sciences Institute of UTSA, UTHSC is accelerating the region’s bioscience momentum
Read this story... |
|
06-06-06
UTSA COLLEGE OF ENGINEERING INTERIM DEAN INSTALLED AS PRESIDENT OF INTERNATIONAL BIOMATERIALS ORGANIZATION
Read this story...
|
06-06-05
Azaya Therapeutics, Inc. Appoints Michael T. Dwyer as President, Chief Executive Officer and Director
Read this story... |
|
12-01-04
FDA Advisory Committee Recommends Accelerated Clofarabine Approval for Most Common Pediatric Leukemia
Read this story...
|
09-07-04
NEW UTSA INSTITUTE HOSTS ACCLAIMED INVENTOR SEPT. 9
Read this story... |
|
07-27-04
Consortium Service Management Group Announces Results of Trauma Surgery Using Patented Tissue-Bonding Technology
Read this story...
|
07-21-04
ILEX Oncology Reports Q2 2004 Results; Development of Key Compounds Advances Ahead of Schedule
Read this story... |
|
07-21-04
FDA Will Grant ILEX´s Clofarabine Additional Six-Month Pediatric Exclusivity; Incentive Provides Extended Patent Protection Upon Marketing Approval
Read this story...
|
07-01-04
ILEX Oncology Shareholders Approve Merger with Genzyme Corporation; Transaction Remains Subject to Federal Trade Commission Clearance
Read this story... |
|
06-23-04
ILEX Announces CAMPATH Front-Line CLL Study Fully Enrolled: Trial Will Evaluate Prolonged Survival in Previously Untreated Patients
Read this story...
|
06-17-04
ILEX Initiates ILX-651 Study in Prostate Cancer; Third Phase II Trial in Solid Tumors Now Underway
Read this story... |
|
06-17-04
Patent Added to Introgen´s Portfolio Establishes Control of Pharmaceutical Adenoviral p53 Products
Read this story...
|
05-28-04
Consortium Service Management Group, Inc. Announces Results of the U.S. Live Biological Tissue Bonding Technology Demonstrations
Read this story... |
|
05-11-04
Consortium Service Management Group, Inc. Receives 2nd Key United States Patent on Its Platform Live Biological Tissue Bonding / Welding Technology
Read this story...
|
03-31-04
ILEX Completes New Drug Application for Clofarabine; Filing Offers Hope to Children with Most Difficult-to-Treat Leukemias
Read this story... |
|
01-27-04
ILEX Oncology Reports Q4 and Full Year 2003 Results; CAMPATH Continues Steady Sales Progression; Company Provides 2004 Outlook
Read this story...
|
10-28-03
OSTEOBIOLOGICS, INC. receives 510(k) Clearance from FDA to Market and Distribute its IMMIX™ PlastiFilm Surgical Mesh
Read this story... |
|
10-08-03
ILEX Initiates ILX-651 Phase II Melanoma Study
Read this story...
|
09-09-03
ILEX Obtains Fast Track Designation for Pediatric Leukemia; Clofarabine Interim Data From Pivotal Trial Shows Hope for Children
Read this story... |
|
|
